Skip to main content

Table 2 Unadjusted hospital mortality in patients with and without COVID-19 (overall and at different levels of frailty) (Also refer to Fig. 2)

From: Impact of frailty on clinical outcomes in patients with and without COVID-19 pneumonitis admitted to intensive care units in Australia and New Zealand: a retrospective registry data analysis

 

Patients with COVID-19, OR (95% CI)

p-value

Patients without COVID-19, OR (95% CI)

p-value

Frailty assessed using CFS as a continuous variable

CFS

1.29 (1.19–1.41)

< 0.001

1.24 (1.11–1.37)

< 0.001

Male sex

1.59 (1.25–2.04)

< 0.001

1.29 (0.94–1.77)

0.12

ANZROD

1.07 (1.06–1.08)

< 0.001

1.05 (1.04–1.06)

< 0.001

  1. CFS: Clinical Frailty Scale; ANZROD: Australian and New Zealand Risk of Death
Back to article page

Critical Care

ISSN: 1364-8535